Compare Virgin Galactic Holdings, Inc. (SPCE) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Virgin Galactic Holdings, Inc. vs Vir Biotechnology Inc. Common Stock — how do they compare? Virgin Galactic Holdings, Inc. trades at $2.54 (market cap $398.70M), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Vir Biotechnology Inc. Common Stock is far larger — about 4.5× Virgin Galactic Holdings, Inc.'s market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Virgin Galactic Holdings, Inc. for 70 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SPCE | VIR | |
|---|---|---|
Market Cap | $398.70M | $1.80B |
Volume | 5,790,856 | 1,782,836 |
Sector | Industrials | Health |
52-Week High | $7.52 | $11.78 |
52-Week Low | $2.17 | $5.12 |
Typical Hold Time | 70 Days | 0 Days |
Enterprise Value | $362.68M | $1.36B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Virgin Galactic (SPCE) trades at $2.63, down 1.5% today, reflecting ongoing investor concerns despite recent earnings beats. The company shows deteriorating fundamentals with negative profit margins and cash flow, though technical indicators suggest potential oversold conditions with RSI readings below 11. Recent news highlights commercial flight delays to 2027 but strong ticket demand, creating mixed sentiment among analysts.
Outlook remains highly speculative with significant execution risks. The path to profitability depends on successful Delta flight commercialization in 2027, but persistent cash burn and high short interest (near 30%) pose substantial downside risks. Analyst consensus is divided, reflecting the binary nature of SPCE's space tourism business model.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
